awards grant
- A Non-Inferiority Randomized Controlled Clinical Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Consequent to MST in Male and Female Military Personnel and Veterans
- A Phase II Study of Inhaled CO for the Treatment of ARDS
- Bacteriophage Therapy Against Multidrug-Resistant Bacteria Causing Serious Wound Infections
- Breaking through immune resistance of HR+ breast cancer
- Breaking through immune resistance of HR+ breast cancer
- Converting HR+ Breast Cancer Into an Individualized Vaccine
- Converting HR+ Breast Cancer Into an Individualized Vaccine
- Defining the Potential of Early Molecular Subtypes of Prostate Cancer to Progress to AR-Indifferent Disease
- Dissecting the Role of APOBEC3 Mutagenic Proteins as Drivers of Genomic-Instability and Chemotherapy-Resistance in Urothelial Carcinoma
- Exosome-mediated thrombosis in pancreatic cancer
- Heating cold prostate tumors with PSMA-targeted alpha therapy and pembrolizumab
- Interplay of DNA methylation and histone methylation driving neuroendocrine phenotype in advanced prostate cancer
- Iron chelation therapy for ovarian cancer: reprogramming the tumor microenvironment and the host microbiome to control disease progression.
- Linker Histone Mutations Mediate Lymphomagenesis Through a Novel Chromatin Mechanism
- Lipid elongation via ELOVL5: a novel target for advanced prostate cancer
- Molecular and clinical correlates with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy
- Molecular and clinical correlates with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy
- Multifunctional Nanofiber for Convection-Enhanced Delivery of Theranostics to Diffuse Intrinsic Pontine Glioma
- Non-occluding Zero-Thickness Inflatable Sensor Arrays for Conformable Mapping and Ablation
- Pharmacologic Inhibition of Lipogenesis Suppresses AR and Its Splice Variants to Inhibit Progression of Castration-Resistant Prostate Cancer
- Probing Mechanisms of P. Falciparum Artemisinin Resistance Using Single Cell Transcriptomics
- Prostate Cancer Clinical Consortium Clinical Research Site: Targeted Therapies
- Regulation of Cardiogenesis by GATA Transcription Factors
- Targeting ART1, a novel immune checkpoint, for the treatment of lung cancer
- Targeting tumor intrinsic immunosuppressive mechanisms to enhance efficacy of immune checkpoint blockade in lung cancer
- Temporal Evolution of N-Myc Signalign and Early Targeting of the Neuroendocrine Phenotype in Prostate Cancer
- Temporal Evolution of N-Myc Signaling and Early Targeting of the Neuroendocrine Phenotype in Prostate Cancer
- The Role of RNA Methylation in Breast Cancer
- The role of EZH2 in lymphomagenesis
- Transferrin Receptor Identifies a Comprehensive pool of Circulating Tumor Cells with unique molecular features from metastatic Prostate Cancer Patients